239
Views
66
CrossRef citations to date
0
Altmetric
Research Article

Lipid, lipase and lipocalin differences between tolerant and intolerant contact lens wearers

, &
Pages 227-235 | Published online: 02 Jul 2009

References

  • Mainstone JC, Bruce AS, Golding TR. Tear meniscus mea-surements in the diagnosis of dry eye. Curr Eye Res. 1996;15:653–661.
  • Glasson MJ, Keay L, Willcox MDP. Understanding the reasons why some patients are intolerant to soft contact lens wear. Invest Ophthalmol Vis Sci. 2000 :41(4): S73.
  • Golding TR, Bruce AS, Mainstone JC. Relationship between tear-meniscus parameters and tear-film breakup. Cornea. 1997;16:649–661.
  • Glasgow BJ, Marshall G, Gasymov OK, Abduragimov AR, Yusifov TN, Knobler CM. Tear lipocalins: Potential lipid scavengers for the corneal surface. Invest Ophthalmol Vis Sci. 1999;40:3100–3107.
  • McCulley JP, Shine W. A compositional based model for the tear film lipid layer. Trans Am Ophthalmol Soc. 1997;95:79–88.
  • Greiner JV, Glonek T, Korb DR, Leahy CD. Meibomian gland phospholipids. Curr Eye Res. 1996;15:371–375.
  • Korb DR, Greiner JV, Glonek T. Tear film lipid layer for-mation: Implications for contact lens wear. Optom Vis Sci. 1996;73:189–192.
  • Shine WE, McCulley JP Keratoconjunctivitis sicca associ-ated with meibomian secretion polar lipid abnormality. Arch Ophthalmol. 1998;116:849–852.
  • Craig JP, Tomlinson A. Importance of the lipid layer in human tear film stability and evaporation. Optom Vis Sci. 1997;74:8–13.
  • Iwata S, Lemp MA, Holly FJ, Dohlman CH. Evaporation rate of water from the precomeal tear film and cornea in the rabbit. Invest Ophthalmol. 1969;8:613–619.
  • Korb DR, Greiner JV, Glonek T, Whalen A, Hearn SL, Esway JE, Leahy CD. Human and rabbit lipid layer and interference pattern observations. Adv Exp Med Biol. 1998;438:305–308.
  • Nicolaides N, Kaitaranta JK, Rawdah TN, Macy II, Boswell FM 3d, Smith RE. Meibomian gland studies: Comparison of steer and human lipids. Invest Ophthalmol Vis Sci. 1981;20: 522–536.
  • King-Smith PE, FinkBA, Fogt N. Three interferometric methods for measuring the thickness of layers of the tear film. Optom Vis Sci. 1999;76:19–32.
  • Redl B, Holzfeind P, Lottspeich F. cDNA cloning and sequencing reveals human tear prealbumin to be a member of the lipophilic-ligand carrier protein superfamily. J Biol Chem. 1992;267:20282–20287.
  • Delaire A, Lassagne H, Gachon AMF. New members of the lipocalin family in human tear fluid. Exp Eye Res. 1992;55:645–647.
  • Gachon AM, Lacazette E. Tear lipocalin and the eye's front line of defence. Br J Ophthalmol. 1998;82:453–455.
  • Glasgow BJ, Abduragimov AR, Farahbakhsh ZT, Faull KF, Hubbell WL. Tear lipocalins bind a broad array of lipid ligands. Curr Eye Res. 1995;14:363–372.
  • Fullard RJ, Kissner DM. Purification of the isoforms of tear specific prealbumin. Curr Eye Res. 1991;10:613–628.
  • Fullard RJ, Snyder C. Protein levels in nonstimulated and stimulated tears of normal human subjects. Invest Oph-thalmol Vis Sci. 1990;31:1119–1126.
  • Evans V, Cordwell S, Vockler C, Willcox MDR Ten isoforms of human tear lipocalin demonstrated with 2D-PAGE and MALDI-TOF analysis. Invest Ophthalmol Vis Sci. 2000:41(4):569.
  • Gasymov OK, Abduragimov AR, Yusifov TN, Glasgow BJ. Structural changes in tear lipocalins with ligand binding. Biochim Biophys Acta. 1998;1386:145–156.
  • Flower DR, North AC, Attwood TK. Structure and sequence relationships in the lipocalins and related pro-teins. Protein Sci. 1993;2:753–761.
  • Nevelainen TJ, Aho HJ, Peuravuori H. Secretion of group 2 phospholipase A2 by lacrimal gland. Invest Ophthalmol Vis Sci. 1994;35: 417–421.
  • Song CH, Choi JS, Kim DK, Kim JC. Enhanced secretory group II PLA2 activity in the tears of chronic blepharitis patients. Invest Ophthalmol Vis Sci. 1999;40:2744–2748.
  • Saari KM, Aho VV, Paavilainen V, Nevalainen TJ. Group II PLA2 content of tears in normal subjects. Invest Ophthal-mol Vis Sci. 2001;42:318–320.
  • Aho H, Saari KM, Kallajoki M, Nevalainen TJ. Synthesis of group II phospholipase A2 and lysozyme in lacrimal glands. Invest Ophthalmol Vis Sci. 199637:1826-1832.
  • Vadas P, Browning J, Edelson J, Pruzanski W. Extracellular phospholipase A2 expression and inflammation: The rela-tionship with associated disease states. J Lipid Mediat. 1993;8:1–30.
  • Harwig SSI, Tan L, Qu XD, Cho Y, Eisenhauer PB, Lehrer RI. Bactericidal properties of murine intestinal phospholi-pase A2. J Clin Invest. 1995;95:603–610.
  • Weinrauch Y, Elsbach P, Madsen LM, Foreman A, Weiss J. The potent anti-staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14 kDa phospholipase A2. J Clin Invest. 1996;97: 250–257.
  • Vadas P, Pruzanski W. Biology of disease: Role of secre-tory phospholipase A2 in the pathobiology of disease. Lab Invest. 1986;55:391–404.
  • Song CH, Choi JS, Kim DK, Kim JC. Enhanced secretory group II PLA2 activity in the tears of chronic blepharitis patients. Invest Ophthalmol Vis Sci. 1999 ;40 :2744–2748.
  • Aho HJ, Saari K, Kallajoki M, Nevalainen TJ. Synthesis of group II phospholipase A2 and lysozyme in lacrimal gland. Invest Ophthalmol Vis Sci. 199637:1826-1832.
  • Zheng L, Zomerdijk TP, Van Den Barselaar MT, Geertsma ME Van Furth R, Nibbering PH. Arachidonic acid, but not its metabolites, is essential for FcgammaR-stimulated intra-cellular killing of Staphylococcus aureus by human mono-cytes . Immunology. 1999;96:90–97.
  • Lennartz MR, Brown EJ. Arachidonic acid is essential for IgG Fc receptor-mediated phagocytosis by human mono-cytes. J Immunol. 1991;147:621–626.
  • Dennis EA, Rhee SG, Billah MIM, Harmun YA. Role of phospholipase in generating lipid second messengers in signal transduction. FASEB J. 1991;5:2068–2077.
  • McMonnies CW. Key questions in a dry eye history. J Am Opt Assoc. 1986;57:512–517.
  • Glasson MJ, Molloy MP, Walsh BJ, Morris CA, Williams KL. Development of mini-gel technology in two-dimensional electrophoresis for mass-screening of samples: Application to tears. Electrophoresis. 1998;19: 652–855.
  • Glasson MJ, Hseuh S, Willcox MDP. Preliminary tear film measurements of tolerant and non-tolerant contact lens wearers. Clin Exp Optom.1999;82:177–181.
  • Carney FP, Morris CA, Willcox MDP. Effect of hydrogel lens wear on the major tear proteins during extended wear. Aust NZ J Ophthalmol. 1997;25:S36–S38.
  • Tan A, Sack RA, Holden BA, Swarbrick HA. Temporal sequence of changes in tear film composition during sleep. Curr Eye Res. 1993;12:1001–1007.
  • Sack RA, Tan KO, Tan A. diurnal tear cycle: Evidence for a nocturnal inflammatory constituitive tear fluid. Invest Ophthalmol Vis Sci. 1992;33:626–640.
  • Fullard RJ, Tucker DL. Changes in human tear protein levels with progressively increasing stimulus. Invest Oph-thalmol Vis Sci. 1991;32:2290–2301.
  • Connor CG, Flockencier LL, Hall CW. The influence of gender on the ocular surface. J Am Opt Assoc. 1999;70:182–186.
  • Mulvenna I, Stapleton F, HaMs PG, Cengiz A, Tan M, Walsh B, Holden B. Low molecular weight analysis of tears using matrix assisted laser desorption ionization-time of flight mass spectrometry. Clin Exp Ophthalmol. 2000;28:205–207.
  • Barton K, Nava A, Monroy DC, Pflugfelder SC. Cytokines and tear function in ocular surface disease. Adv Exp Med Biol. 1998;438:461–469.
  • Gachon A-M, Richard J, Dastugue B. Human tears: Normal protein pattern and individual protein determinations in adults. Curr Eye Res. 1983;2:301–308.
  • Tomlinson A, Pearce El, Simmons PA, Blades K. Effect of oral contraceptives on tear physiology. Ophthal Physiol Opt. 2001;21:9–16.
  • Willcox MDP, Lan J. Secretory immunoglobulin A in tears: Functions and changes during contact lens wear. Clin Exp Optom. 1999;82:1–3.
  • Stapleton F, Willcox MDP, Morris CA, Sweeney DF. Tear changes in contact lens wearers following overnight eye closure. Curr Eye Res. 1998;17:183–188.
  • Carney FP, Keay L, Stapleton F, Morris CA, Willcox MDP. Hydrogel lens wettability and deposition in vivo. Clin Exp Optom. 1998;81:51–55.
  • Guillon JP, Guillon M. Tear film examination of the contact lens patient. Contax. 1998;May:14–18.
  • Baeir G, Wollensak G, Mur E, Redl B, Stoffler G, Gottinger W. Analysis of human tear proteins by different high-performance chromatographic techniques. J Chromatogr. 1990;525:319–328.
  • Erdfelder E, Faul F, Buchner A. GPOWER: A general power analysis program. Behaviour Res Methods, Instruments & Computers. 1996;28:1–11.
  • Hair JF, Anderson RE, Tatham RL, Black WC. Multivari-ate Data Analysis. 4th ed. New Jersey: Prentice-Hall Inc; 1995:204–205.
  • Papas EB, Vajdic CM. Inter-ocular characteristics of the pre-contact lens tear film. Curr Eye Res. 2000;20:248–250.
  • Jumblatt MIM, McKenzie RW, Jumblatt JE. Mucins of the ocular surface. Cornea. 2000;19(Suppl 2): S97.
  • Murty VLN, Sarosiek J, Slomiany A, Slomiany BL. Effect of lipids and proteins on the viscosity of gastric mucus gly-coproteins. Biochem Biophys Res Comm. 1984;121:521–529.
  • Gong DH, Turner B, Bhaskar KR, Lamont JT. Lipid binding to gastric mucin: Protective effect against oxygen radicals. Am J Physiol. 1990;259:G681–G686.
  • Shine WE, McCulley JP. Association of meibum oleic acid with meibomian seborrhea. Cornea. 2000;19:72–74.
  • McMonnies CW, Ho A, Wakefield D. Optimum dry eye classification using questionnaire responses. In: Sullivan DA et al., eds. Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2. New York: Plenum Press; 1998:835–838.
  • Boyaka PN, McGhee JR. Cytokines as adjuvants for the induction of mucosal immunity. Adv Drug Deliv Rev. 2001;51:71–79.
  • Yomogida S, Nagaoka I, Saito K, Yamashita T. Evaluation of the effects of defensins on neutrophil functions. Inflamm Res. 1996;45:62–67.
  • Yang D, Chertov 0, Oppenheim JJ. Participation of mammalian defensins and cathelicidins in anti-microbial immunity: Receptors and activities of human defensins and cathelicidin (LL-37). J Leukoc Biol. 2001;69: 691–697.
  • McNamara NA, Van R, Tuchin OS, Fleiszig SM. Ocular surface epithelia express mRNA for human beta defensin-2. Exp Eye Res. 1999;69:483–490.
  • Redl B, Wojnar P, Ellemunter H, Feichtinger H. Identifica-tion of a lipocalin in mucosal glands of the human tra-cheobronchial tree and its enhanced secretion in cystic fibrosis. Lab Invest. 1998;78:1121–1129.
  • Tiffany JM, Pandit JC, Bron AJ. Soluble mucin and the physical properties of tears. In: Sullivan DA et al., eds. Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2. New York, USA: Plenum Press; 1998:229–234.
  • Nagyova B, Tiffany JM. Components responsible for the surface tension of human tears. Curr Eye Res. 1999;19: 4–11.
  • Pandit JC, Nagyova B, Bron AJ, Tiffany JM. Physical prop-erties of stimulated and unstimulated tears. Exp Eye Res. 1999;68:247–253.
  • Greiner JV, Glonek T, Korb DR, Leahy CD. Meibomian gland phospholipids. Curr Eye Res. 1996;15:371–375.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.